What is the Future of Molecular Pathology in Gynecology?
The future of molecular pathology in gynecology is promising, with continuous advancements in technology and research. Emerging areas include:
Liquid biopsy: A non-invasive method to detect cancer through the analysis of circulating tumor DNA in blood. Epigenetics: Studying changes in gene expression that do not involve alterations in the DNA sequence, offering new insights into disease mechanisms and potential treatments. Integration of artificial intelligence and machine learning to analyze complex molecular data, improving diagnostic accuracy and treatment planning.
These advancements will likely lead to even more personalized and effective healthcare for women.